Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Bennett, Charles
Item TypeName
Concept Anemia
Concept Anemia, Hypochromic
Concept Anemia, Sickle Cell
Academic Article Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.
Academic Article Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents.
Academic Article Editorial Comment.
Academic Article Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.
Academic Article The blue cross blue shield assessment technology review: summary of findings.
Academic Article Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review.
Academic Article Clinical characteristics of erythropoietin-associated pure red cell aplasia.
Academic Article Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis.
Academic Article Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients.
Academic Article Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.
Academic Article Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.
Academic Article Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin.
Academic Article Epoetin-associated pure red cell aplasia: past, present, and future considerations.
Academic Article Cancer- and chemotherapy-induced anemia.
Academic Article Intersecting guidelines: administering erythropoiesis-stimulating agents to chronic kidney disease patients with cancer.
Academic Article Reassessments of ESAs for cancer treatment in the US and Europe.
Academic Article American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
Academic Article American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
Academic Article Risks of Venous Thromboembolism and Mortality Associated With Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Associated Anemia.
Academic Article Emerging drugs for treatment of anemia of chronic kidney disease.
Academic Article Forewarned is forearmed: erythropoietin use in CKD patients with cancer.
Academic Article Anaphylaxis and hypotension after administration of peginesatide.
Academic Article Is Intravenous Iron Supplementation Safe to Administer to Patients on Hemodialysis with Active Infection--What Do We Know, and What More Do We Need to Know?
Academic Article Consensus on the Existence of Functional Erythropoietin Receptors on Cancer Cells.
Academic Article Peginesatide for the treatment of anemia due to chronic kidney disease - an unfulfilled promise.
Academic Article Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced Anemia.
Academic Article End of an era for erythropoiesis-stimulating agents in oncology.
Academic Article Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
Academic Article The First 2?Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.
Academic Article End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemia.
Search Criteria
  • Anemia